AAAAAA

   
Results: 1-15 |
Results: 15
FIGHTING HEART-DISEASE AND STROKE - RECOMMENDATIONS OF THE AHA STROKEPOSITIONING TASK-FORCE
Authors: STRAUSS WE THIES WH ROBERTSON RM ADAMS H
Citation: We. Strauss et al., FIGHTING HEART-DISEASE AND STROKE - RECOMMENDATIONS OF THE AHA STROKEPOSITIONING TASK-FORCE, Stroke, 29(6), 1998, pp. 1272-1273
TASK-FORCE 5 - STRATIFICATION OF PATIENTS INTO HIGH, MEDIUM AND LOW-RISK SUBGROUPS FOR PURPOSES OF RISK FACTOR MANAGEMENT
Authors: CALIFF RM ARMSTRONG PW CARVER JR DAGOSTINO RB STRAUSS WE
Citation: Rm. Califf et al., TASK-FORCE 5 - STRATIFICATION OF PATIENTS INTO HIGH, MEDIUM AND LOW-RISK SUBGROUPS FOR PURPOSES OF RISK FACTOR MANAGEMENT, Journal of the American College of Cardiology, 27(5), 1996, pp. 1007-1019
TISSUE FACTOR PATHWAY INHIBITOR (TFPI) ACTIVITY IN UREMIC PATIENTS DURING HEMODIALYSIS
Authors: CELLA G VERTOLLI U NASO A VIANELLO A RAMPIN E SBARAI A BOERI G STRAUSS WE
Citation: G. Cella et al., TISSUE FACTOR PATHWAY INHIBITOR (TFPI) ACTIVITY IN UREMIC PATIENTS DURING HEMODIALYSIS, Thrombosis research, 81(6), 1996, pp. 671-677
ADEQUACY OF PRESCRIBING PRACTICES FOR PATIENTS RECEIVING HMG COA REDUCTASE INHIBITOR TREATMENT - RESULTS OF A TIERED UTILIZATION REVIEW
Authors: STRAUSS WE ALEXIS G TAPLEY R LEVERONE R
Citation: We. Strauss et al., ADEQUACY OF PRESCRIBING PRACTICES FOR PATIENTS RECEIVING HMG COA REDUCTASE INHIBITOR TREATMENT - RESULTS OF A TIERED UTILIZATION REVIEW, Circulation, 94(8), 1996, pp. 2441-2441
LONG-TERM BENEFITS IN QUALITY-OF-LIFE SCORES IN PATIENTS TREATED WITHANGIOPLASTY VS MEDICAL THERAPY - 5-YEAR RESULTS FROM THE ACME TRIAL
Authors: STRAUSS WE HARTIGAN P FOLLAND E PARISI A
Citation: We. Strauss et al., LONG-TERM BENEFITS IN QUALITY-OF-LIFE SCORES IN PATIENTS TREATED WITHANGIOPLASTY VS MEDICAL THERAPY - 5-YEAR RESULTS FROM THE ACME TRIAL, Circulation, 94(8), 1996, pp. 4264-4264
CONTROL OF HEART-RATE DURING TRANSITION FROM INTRAVENOUS OF ORAL DILTIAZEM IN FIBRILLATION OR FLUTTER
Authors: BLACKSHEAR JL STAMBLER BS STRAUSS WE ROY D DIAS VC BEACH CL EBENER MK
Citation: Jl. Blackshear et al., CONTROL OF HEART-RATE DURING TRANSITION FROM INTRAVENOUS OF ORAL DILTIAZEM IN FIBRILLATION OR FLUTTER, The American journal of cardiology, 78(11), 1996, pp. 1246-1250
INCREASE IN CIRCULATING PRODUCTS OF LIPID-PEROXIDATION (F-2-ISOPROSTANES) IN SMOKERS - SMOKING AS A CAUSE OF OXIDATIVE DAMAGE
Authors: MORROW JD FREI B LONGMIRE AW GAZIANO JM LYNCH SM SHYR Y STRAUSS WE OATES JA ROBERTS LJ
Citation: Jd. Morrow et al., INCREASE IN CIRCULATING PRODUCTS OF LIPID-PEROXIDATION (F-2-ISOPROSTANES) IN SMOKERS - SMOKING AS A CAUSE OF OXIDATIVE DAMAGE, The New England journal of medicine, 332(18), 1995, pp. 1198-1203
UNTITLED
Authors: STRAUSS WE
Citation: We. Strauss, UNTITLED, Chest, 108(3), 1995, pp. 885-885
POOR R-WAVE PROGRESSION IN PRECORDIAL LEADS - DIFFERENTIATION BETWEENANTERIOR MYOCARDIAL-INFARCTION AND CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
Authors: SHARMA GVRK ROCCO TP STRAUSS WE PIETRO DA MCINTYRE KM MCCAUGHAN D
Citation: Gvrk. Sharma et al., POOR R-WAVE PROGRESSION IN PRECORDIAL LEADS - DIFFERENTIATION BETWEENANTERIOR MYOCARDIAL-INFARCTION AND CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, Circulation, 92(8), 1995, pp. 2577-2577
A COMPARISON OF QUALITY-OF-LIFE SCORES IN PATIENTS WITH ANGINA-PECTORIS AFTER ANGIOPLASTY COMPARED WITH AFTER MEDICAL THERAPY - OUTCOMES OFA RANDOMIZED CLINICAL-TRIAL
Authors: STRAUSS WE FORTIN T HARTIGAN P FOLLAND ED PARISI AF
Citation: We. Strauss et al., A COMPARISON OF QUALITY-OF-LIFE SCORES IN PATIENTS WITH ANGINA-PECTORIS AFTER ANGIOPLASTY COMPARED WITH AFTER MEDICAL THERAPY - OUTCOMES OFA RANDOMIZED CLINICAL-TRIAL, Circulation, 92(7), 1995, pp. 1710-1719
SAFETY AND EFFICACY OF INTRAVENOUS DILTIAZEM IN ATRIAL-FIBRILLATION OR ATRIAL-FLUTTER
Authors: ELLENBOGEN KA DIAS VC CARDELLO FP STRAUSS WE SIMONTON CA POLLAK SJ WOOD MA STAMBLER BS
Citation: Ka. Ellenbogen et al., SAFETY AND EFFICACY OF INTRAVENOUS DILTIAZEM IN ATRIAL-FIBRILLATION OR ATRIAL-FLUTTER, The American journal of cardiology, 75(1), 1995, pp. 45-49
ANTIPLATELET EFFECTS OF A NOVEL ANTIANGINAL AGENT, NICORANDIL
Authors: JARAKI O STRAUSS WE FRANCIS S LOSCALZO J STAMLER JS
Citation: O. Jaraki et al., ANTIPLATELET EFFECTS OF A NOVEL ANTIANGINAL AGENT, NICORANDIL, Journal of cardiovascular pharmacology, 23(1), 1994, pp. 24-30
ELECTROCARDIOGRAPHIC CHANGES ASSOCIATED WITH NEUROLOGIC EVENTS
Authors: STRAUSS WE SAMUELS MA
Citation: We. Strauss et Ma. Samuels, ELECTROCARDIOGRAPHIC CHANGES ASSOCIATED WITH NEUROLOGIC EVENTS, Chest, 106(5), 1994, pp. 1316-1317
CONTROL OF HEART-RATE DURING TRANSITION FROM IV TO ORAL DILTIAZEM IN PATIENTS WITH RAPID ATRIAL-FIBRILLATION OR FLUTTER - RESULTS OF A MULTICENTER TRIAL
Authors: BLACKSHEAR JL STAMBLER BS STRAUSS WE DIAS VC BEACH CL EBENER MK
Citation: Jl. Blackshear et al., CONTROL OF HEART-RATE DURING TRANSITION FROM IV TO ORAL DILTIAZEM IN PATIENTS WITH RAPID ATRIAL-FIBRILLATION OR FLUTTER - RESULTS OF A MULTICENTER TRIAL, Circulation, 90(4), 1994, pp. 375-375
CONTROL OF HEART-RATE DURING TRANSITION FROM IV TO ORAL DILTIAZEM IN PATIENTS WITH RAPID ATRIAL-FIBRILLATION OR FLUTTER - RESULTS OF A MULTICENTER TRIAL
Authors: BLACKSHEAR JL STAMBLER BS STRAUSS WE DIAS VC BEACH CL EBENER MK
Citation: Jl. Blackshear et al., CONTROL OF HEART-RATE DURING TRANSITION FROM IV TO ORAL DILTIAZEM IN PATIENTS WITH RAPID ATRIAL-FIBRILLATION OR FLUTTER - RESULTS OF A MULTICENTER TRIAL, Circulation, 90(4), 1994, pp. 375-375
Risultati: 1-15 |